FARLETUZUMAB ECTERIBULIN

UNII:	UVG3B5TZN3
Formula:
Preferred Substance Name:	FARLETUZUMAB ECTERIBULIN
GSRS Full Record:	UVG3B5TZN3 i

2407465-18-1
ERIBULIN/FARLETUZUMAB ANTIBODY DRUG CONJUGATE
FARLETUZUMAB ECTERIBULIN [INN]
FARLETUZUMAB ECTERIBULIN [USAN]
FARLETUZUMAB ECTERIBULIN [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN FOLATE RECEPTOR .ALPHA.) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER, REDUCED, THIOETHER WITH N-(3-(2-(2-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)ETHOXY)ETHOXY)-1-OXOPROPYL)-L-VALYL-N5-(AMINOCARBONYL)-N-(4-((((((2S)-3-((2R,3R,3AS,7R,8AS,9S,10AR,11S,12R,13AR,13BS,15S,18S,21S,24S,26R,28R,29AS)-OCTACOSAHYDRO-3-METHOXY-26-METHYL-20,27-BIS(METHYLENE)-5-OXO-11,15:18,21:24,28-TRIEPOXY-7,9-ETHANO-12,15-METHANO-9H,15H-FURO(3,2-I)FURO(2',3':5,6)PYRANO(4,3-B)(1,4)DIOXACYCLOPENTACOSIN-2-YL)-2-HYDROXYPROPYL)AMINO)CARBONYL)OXY)METHYL)PHENYL)-L-ORNITHINAMIDE
MORAB-202

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

FARLETUZUMAB ECTERIBULIN

Synonyms and Mappings

Resources